| human | Q5 |
| P496 | ORCID iD | 0000-0002-1885-8430 |
| P735 | given name | Edwin | Q240931 |
| Edwin | Q240931 | ||
| P106 | occupation | researcher | Q1650915 |
| Q90731240 | A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation |
| Q36402045 | A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. |
| Q43458651 | Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome |
| Q33815631 | Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. |
| Q35533586 | Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions. |
| Q47402442 | Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease |
| Q24539030 | Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission |
| Q37123927 | Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells |
| Q36212400 | Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation |
| Q36920466 | Circulating T follicular helper cells with increased function during chronic graft-versus-host disease |
| Q35687151 | Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation |
| Q37183578 | Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation |
| Q24673367 | Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis |
| Q35769347 | Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival |
| Q48228263 | Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias |
| Q37685590 | Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. |
| Q93021290 | Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children |
| Q37076418 | Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease |
| Q58415140 | Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy |
| Q64089252 | Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease |
| Q24670205 | Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor |
| Q58415027 | Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation |
| Q34577019 | Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. |
| Q36036340 | Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. |
| Q74453125 | Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells |
| Q35525729 | Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation. |
| Q59315342 | Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O |
| Q42737854 | Prediction of veno-occlusive disease using biomarkers of endothelial injury |
| Q93115037 | Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report |
| Q58415147 | Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion |
| Q35848361 | Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease |
| Q46816156 | Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts |
| Q39143739 | Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation |
| Q34396189 | Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation |
| Q97541727 | Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients |
| Q34827332 | Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation |
| Q33650918 | White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome |
Search more.